Total:1,685    Page:69/113
First << 67 68 69 70 71 ... >> Last To Page Go  
Structure Name MW ACS No Drugbank_ID Formula Status
molecular structure Hydrocortisone 362.466 50-23-7 DB00741 C21H30O5 FDA approved
molecular structure Solifenacin 362.473 242478-38-2 DB01591 C23H27N2O2 FDA approved
molecular structure Cefadroxil 363.394 66592-87-8 DB01140 C16H17N3O5S FDA approved
molecular structure Bucindolol 363.461 C22H26N3O2
molecular structure Talinolol 363.502 38649-73-9 C20H34N3O3
molecular structure Zolpidem 363.505 82626-48-0 DB00425 C23H29N3O FDA approved
molecular structure Auranofin 364.371 34031-32-8 DB00995 C14H20O9S FDA approved
molecular structure Tyloxapol 364.401 25301-02-4 DB06439 C21H20N2O4 FDA approved
molecular structure Bumetanide 364.422 28395-03-1 DB00887 C17H19N2O5S FDA approved
molecular structure Quinestrol 364.529 152-43-2 DB04575 C25H32O2 FDA approved
molecular structure Fludarabine 365.214 21679-14-1 DB01073 C10H11FN5O7P FDA approved
molecular structure Amoxicillin 365.41 26787-78-0 DB01060 C16H19N3O5S FDA approved
molecular structure Propericiazine 365.501 2622-26-6 DB01608 C21H24N3OS FDA approved
molecular structure Trimethaphan 365.521 7187-66-8 DB01116 C22H25N2OS FDA approved
molecular structure Clinafloxacin 365.792 105956-99-8 C17H17ClFN3O3 Clinical trial - Phase III, Clinical trial